Carlotta Becherini

Azienda Ospedaliero-Universitaria Careggi

Papers

3

Total Citations

49

H-Index

3

About

Carlotta Becherini is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) and robotic radiosurgery for early-stage and oligometastatic cancers. Her most impactful work centers on the paradigm-shifting use of preoperative partial breast irradiation (PBI), as demonstrated by her role in the phase II ROCK trial (NCT03520894). This study, which has garnered 29 citations, pioneered the use of robotic radiosurgery to treat a well-defined breast tumor target before surgical excision, offering a potential alternative to conventional whole-breast irradiation. Becherini has also made significant contributions to the management of colorectal cancer liver metastases, showing in a 2019 study (17 citations) that robotic stereotactic radiotherapy provides a safe, effective, and non-invasive option for oligometastatic disease. Her research is characterized by rigorous clinical trial methodology and a commitment to personalizing treatment, reducing toxicity, and improving patient quality of life. By integrating advanced radiation technologies into early-stage disease pathways, Becherini is helping to redefine the standard of care in breast and liver oncology.

Research Focus

Key Achievements

3
H-Index
3
Papers
49
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)
29 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 96
🏛 Institutions: Azienda Ospedaliero-Universitaria Careggi

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago